UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

Gene mutations have consequences both good and bad—from resistance to conditions like diabetes to susceptibility to certain ...

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi ... The company uses ...

Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause ...

In immune organs, plasma cells, which produce antibodies, and cells with specific structures and functions are the main ...

Eledon Pharmaceuticals, Inc. (Eledon), is a biotechnology company ... which prevents the transport of glucose from the blood ...

The aging and failure of cells that occurs when the liver is damaged can spread to other organs, suggests a new study in mice ...

Agentic AI has the potential to reshape not just healthcare, but the very foundations of biological research. By allowing ...

Microfluidic chips that mimic the complex human cervical environment provide a platform to study the reproductive tract and ...